Jacobs Levy Equity Management
ONCR

Jacobs Levy Equity Management’s Oncorus, Inc. ONCR Stock Holding History

Jacobs Levy Equity Management’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-77,651
Closed -$409K – 1109
2021
Q4 		$409K Buy
+77,651
New +$601K ﹤0.01% 861

Other funds holding ONCR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Jacobs Levy Equity Management's ONCR Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of Oncorus, Inc. (ONCR) in Q1 2022, closing a stake of 77,651 shares — an estimated $409K sold.

Jacobs Levy Equity Management first reported a position in ONCR in Q4 2021 and held it in 1 quarter. The position peaked at $409K in Q4 2021. 56 funds tracked by Wall St. Rank hold ONCR as of Q1 2022.

  • Jacobs Levy Equity Management reported no remaining Oncorus, Inc. position as of Q1 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 77,651 Oncorus, Inc. shares in Q1 2022, an estimated $409K.
  • Jacobs Levy Equity Management first reported a position in Oncorus, Inc. in Q4 2021 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Oncorus, Inc. position peaked at $409K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.